Active surveillance vs. surgery in low‐risk papillary thyroid microcarcinoma patients and the risk of loss to follow‐up
Open Access
- 28 August 2024
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 13 (16) , e70123
Abstract
Background: Papillary thyroid microcarcinoma (PTMC) management has evolved, with active surveillance (AS) gaining prominence as a management option. However, a key concern for both clinicians and patients is the potential for patient loss to follow‐up during AS.Aims: This study aimed to determine adherence and loss‐to‐follow‐up rates in low‐risk PTMC patients undergoing AS versus surgical intervention, in order to gain insights into clinical pathways and safety profiles.Materials and Methods: This cohort study analyzed the 2016 data from a single registered institution of Japan's public National Cancer Registry.Results: We identified and retrospectively analyzed the cases of 327 patients diagnosed with low‐risk PTMC; 227 patients chose to undergo AS while the other 100 underwent PTMC surgery. Main outcomes were the adherence rate and loss‐to‐follow‐up rate of each group, factors influencing discontinuation, and safety considerations. The rate of AS adoption was substantial in the complete series of 327 low‐risk PTMC patients (69.4%). There was a significantly higher loss‐to‐follow‐up rate at 5 years in the AS group (28.6%) compared to the Surgery group (17.8%) (HR 1.62, 95% CI: 1.01–2.61; p = 0.046). Both univariate and multivariate analyses confirmed the significantly higher loss‐to‐follow‐up rate in the AS group as well as in older patients. No deaths due to PTMC progression were observed in the cases lost to follow‐up.Conclusion: Despite concerns about loss to follow‐up, active surveillance remains a safe option for low‐risk PTMCs. Consistent follow‐up strategies are crucial, and further research is needed to enhance patient counseling and care for the management of patients with PTMC.Keywords
This publication has 24 references indexed in Scilit:
- Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for YearsThyroid®, 2016
- Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for The Health Care SystemEndocrine Practice, 2016
- A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary MicrocarcinomaThyroid®, 2016
- Antidepressant Self-Discontinuation: Results From the Collaborative Psychiatric Epidemiology SurveysPsychiatric Services, 2015
- Risk factors associated with default among tuberculosis patients in Darjeeling district of West Bengal, IndiaJournal of Family Medicine and Primary Care, 2015
- Revisiting the Guidelines Issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: A Gradual Move Towards Consensus Between Japanese and Western Practice in the Management of Thyroid CarcinomaWorld Journal of Surgery, 2014
- Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 CasesWorld Journal of Surgery, 2013
- Lymph Node Metastasis From 259 Papillary Thyroid MicrocarcinomasAnnals of Surgery, 2003
- Papillary microcarcinoma of the thyroidJournal of Endocrinological Investigation, 1998
- Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period.1992